128 related articles for article (PubMed ID: 8006881)
1. Systemic lupus erythematosus--disease activity, severity, treatment and costs.
Isenberg DA; Shortall E; Newman S
J Rheumatol; 1994 Mar; 21(3):394-6. PubMed ID: 8006881
[No Abstract] [Full Text] [Related]
2. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.
Lacaille D; Clarke AE; Bloch DA; Danoff D; Esdaile JM
J Rheumatol; 1994 Mar; 21(3):448-53. PubMed ID: 8006887
[TBL] [Abstract][Full Text] [Related]
3. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus--disease activity, severity, treatment, and costs.
Clarke AE; Esdaile JM
J Rheumatol; 1995 Jan; 22(1):189-90. PubMed ID: 7755769
[No Abstract] [Full Text] [Related]
5. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
Griffiths B; Mosca M; Gordon C
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
[TBL] [Abstract][Full Text] [Related]
6. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
Clarke AE; Bloch DA; Danoff DS; Esdaile JM
J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of lupus.
Clarke A
Am J Manag Care; 2001 Oct; 7(16 Suppl):S496-501. PubMed ID: 11680782
[TBL] [Abstract][Full Text] [Related]
8. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of systemic lupus erythematosus in Asia: the current state.
Mak A
Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
[TBL] [Abstract][Full Text] [Related]
11. [Quality of life predictors among patients suffering from systemic lupus erythematosus].
Miniszewska J; Juczyński Z; Sysa-Jedrzejowska A; Zalewska A; Wozńiacka A
Przegl Lek; 2006; 63(4):188-90. PubMed ID: 17080741
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
[TBL] [Abstract][Full Text] [Related]
13. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
14. The relationship between disease activity and quality of life in systemic lupus erythematosus.
Khanna S; Pal H; Pandey RM; Handa R
Rheumatology (Oxford); 2004 Dec; 43(12):1536-40. PubMed ID: 15342925
[TBL] [Abstract][Full Text] [Related]
15. The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.
Zhu TY; Tam LS; Li EK
Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):53-69. PubMed ID: 22280197
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in systemic lupus erythematosus.
Panopalis P; Clarke AE
Clin Dev Immunol; 2006; 13(2-4):321-4. PubMed ID: 17162373
[TBL] [Abstract][Full Text] [Related]
17. Costs of illness and quality of life in patients with systemic lupus erythematosus in South Korea.
Cho JH; Chang SH; Shin NH; Choi BY; Oh HJ; Yoon MJ; Lee EY; Lee EB; Lee TJ; Song YW
Lupus; 2014 Aug; 23(9):949-57. PubMed ID: 24563501
[TBL] [Abstract][Full Text] [Related]
18. Cost of treatment of childhood-onset systemic lupus erythematosus.
Brunner HI; Sherrard TM; Klein-Gitelman MS
Arthritis Rheum; 2006 Apr; 55(2):184-8. PubMed ID: 16583393
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
Brunner HI; Higgins GC; Wiers K; Lapidus SK; Olson JC; Onel K; Punaro M; Ying J; Klein-Gitelman MS; Seid M
J Rheumatol; 2009 Jul; 36(7):1536-45. PubMed ID: 19487266
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants.
Doria A; Rinaldi S; Ermani M; Salaffi F; Iaccarino L; Ghirardello A; Zampieri S; Della Libera S; Perini G; Todesco S
Rheumatology (Oxford); 2004 Dec; 43(12):1580-6. PubMed ID: 15367746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
